S1. Detailed information about participantsHere, we detail the inclusion/exclusion criteria for recruitment and information about medications. Those with lifetime psychotic disorders, substance dependence, bipolar disorder or ADHD were excluded, in addition to those with hoarding as a primary symptom. We allowed comorbid anxiety disorders, dysthymic disorder, depressive disorder not otherwise specified, and major depressive disorder with ADIS-IV clinical significance rating score < 6. Thirty-three participants met criteria for at least one such psychiatric comorbidity, while twelve had none.Two participants had comorbid panic disorder, 9 had generalized anxiety disorder, 17 had social anxiety disorder, 7 had major depressive disorder, 2 had dysthymia, 4 had body dysmorphic disorder, 1 had post-traumatic stress disorder, 6 had specific phobia and 1 had depressive disorder not otherwise specified. Fifteen participants took serotonin-reuptake inhibitors (6 fluoxetine, 2 escitalopram, 4 sertraline, 2 paroxetine, 1 fluvoxamine), while 29 were unmedicated. The medicated individuals did not have any changes in agent or dose for 12 weeks prior to enrollment. Fourteen unmedicated OCD individuals took psychiatric medications in the past, while sixteen were psychiatric medication-naïve. An IQ <80 on the Wechsler Abbreviated Scales of Intelligence (WASI) and medical conditions that affected cerebral metabolism like thyroid disorders, diabetes, seizures, brain tumors, a history of stroke, and multiple sclerosis were the other exclusion criteria. HCs were recruited via internet ads and flyers. They had no psychiatric disorders or substance abuse disorders and no current psychoactive medications or major medical conditions. The primary clinical measure for OCD was the Yale-Brown Obsessive-Compulsive Scale (YBOCS) [1]. We obtained secondary measures, viz. Montgomery-Åsberg Depression Rating Scale (MADRS) [2] and Hamilton Anxiety Scale (HAMA) [3]. Social and occupational performance and general functionality were rated using the Global Assessment Scale (GAS) [4].
S2. Relationship of the HRF to normal brain functionTo test the relationship of the HRF to normal brain function, we performed a pilot proof of concept analysis using handedness, with the hypothesis that the HRF is sensitive to normal brain function. This index, the Edinburgh Handedness Scale [5], was acquired for assessment and screening purposes in our HC sample and reflects longstanding patterns of motor behavior.